City
Epaper

Paracetamol can do more harm than good, shouldn't be prescribed for chronic pain

By Lokmat English Desk | Updated: August 5, 2020 12:18 IST

Open in App
1 / 8
PAINKILLERS such as paracetamol, ibuprofen, and aspirin can do more harm than good for chronic pain, health officials have said.
2 / 8
New draft guidance from the National Institute for Health and Care Excellence (Nice) urged doctors not to prescribe the drugs to people suffering the condition.
3 / 8
Nice said there was 'little or no evidence' the commonly used drugs made any difference to a patient's health, quality of life, pain or psychological distress.
4 / 8
And the new guidance, published on Monday, said there was evidence they can cause harm - such as addiction.
5 / 8
Chronic pain is a condition which cannot be accounted for by another diagnosis or as a symptom of an underlying condition.
6 / 8
It can lead to depression and disability - with the pain being felt in the muscles and skeleton, or even all over the body.
7 / 8
Nice said an estimated third to half of the population may be affected by chronic pain. Meanwhile, almost half of people with the condition have a diagnosis of depression and two-thirds are unable to work because of it.
8 / 8
Last year, Health Secretary Matt Hancock said he was “incredibly concerned” by the rising trend of doctors prescribing pain pills, sleeping tablets and anti-depressant.
Open in App

Related Stories

EntertainmentAnees Bazmee celebrates 28 years of "Deewana Mastana" starring Anil Kapoor, Govinda & Juhi Chawla

NationalSecond missing Indian Army soldier’s body recovered in forests of J&K’s Anantnag district

Health6 Types of People Who Should Avoid Sugarcane Juice or Drink It With Caution

EntertainmentHrithik Roshan to step into OTT as producer with upcoming thriller ‘Storm’

NationalSC issues notice on PIL challenging ban on prisoners’ voting rights

Health Realted Stories

HealthMental health fundamental to our overall well-being: PM Modi

HealthIndian professionals hesitant to make mental health conversations at work: Report

HealthCelltrion wins US FDA approval for eye treatment biosimilar

HealthWorld Mental Health Day: JP Nadda calls for prioritising emotional and mental well-being

HealthBehavioural therapies may be effective at treating irritable bowel syndrome